Increase Internship Diversity with Project Onramp

Posted by ISPE Boston
On January 20, 2022

Many undergraduates from low-income backgrounds are not aware of the breadth of career paths in the pharma industry, nor do they have access to information about available summer opportunities. This is where Project Onramp comes in. Project Onramp sources paid summer internships for students who are under-resourced and often from under-represented groups or first-generation – […]

Pfizer and Beam Collaborate on Base Editing Programs for Rare Diseases

Posted by ISPE Boston
On January 19, 2022

Cambridge-based Beam Therapeutics has entered into an exclusive four-year research collaboration with Pfizer focused on in vivo base editing programs for three targets for rare genetic diseases of the liver, muscle and central nervous system. The base editing programs to be evaluated as part of the collaboration will leverage Beam’s proprietary in vivo delivery technologies, which use messenger RNA (mRNA) […]

The Gifts that Keep on Giving!

Posted by Olesya Jaganathan
On January 19, 2022

As we say goodbye to 2021 and look forward to brighter days ahead, the first Annual ISPE Boston Area Chapter’s Women in Pharma (WIP) Holiday Card and Gift Swap was a big success and just what we needed to wrap up the busy year. Pictured is my gift – which bodes well for new growth in 2022! We […]

A fun time had by all at the 1/7 WIP Pasta With Pietro Event

Posted by Caren Jenkins
On January 18, 2022

Buono! Squisito! Gustoso! Saporito! Spettacolare! Delizioso! All these expressions and more were being heard emanating from home kitchens far and wide during last Friday evening’s WIP Boston ISPE Pasta with Pietro. ISPE members, friends, kids, and families from all over including Missouri, Pennsylvania, California, Wisconsin, and even Leinster, Ireland logged on to the second annual […]

Moderna Starts EBV Virus Vaccine Phase 1 Study

Posted by ISPE Boston
On January 6, 2022

Moderna has announced that the first participant has been dosed in its Phase 1 study of mRNA-1189, the company’s Epstein-Barr Virus (EBV) vaccine candidate. Said Moderna CEO Stéphane Bancel, “The start of this Phase 1 study is a significant milestone as we continue to advance mRNA vaccines against latent viruses, which remain in the body […]

Biogen Drops Price for Alzheimer Drug, Plans Cost Reductions

Posted by ISPE Boston
On January 6, 2022

Biogen has announced that it will cut the price of its Alzheimer’s drug Aduhelm in the U.S. by about half, bringing the yearly cost of the maintenance dose to $28,200 per patient. Biogen is taking this action with the goal of lowering out-of-pocket expenses for patients and reducing the potential financial implications for the U.S. […]

Chapter Member Anniversaries: January 2022

Posted by ISPE Boston
On January 4, 2022

Please congratulate the following members celebrating milestone anniversaries in January 2022. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael Anderson, FST Technical Services LLC Mara Bartos, Sanofi Genzyme Daniel Baxter, Vertex Pharmaceuticals Incorporated Anthony Bevilacqua, Mettler-Toledo Thornton Inc William Bohnaker, Abzena Erik Caldwell, Northeast Water Svcs, […]

Welcome New Members December 2021!

Posted by ISPE Boston
On January 4, 2022

We would like to introduce the Members who joined ISPE in December 2021, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Seasons Greetings from ISPE Boston!

Posted by ISPE Boston
On December 22, 2021

There is no more fitting time to say Thank You and to wish our volunteers, board of directors, committee members, and members a Happy Holiday Season and a New Year filled with health, happiness and good fortune. We sincerely appreciate everything you all do to support ISPE and wouldn’t be where we are today without […]

Lilly and Foghorn Announce Strategic Collaboration

Posted by ISPE Boston
On December 16, 2021

Foghorn Therapeutics and Loxo Oncology at Lilly, a research and development group of Eli Lilly, have entered into a strategic collaboration to create novel oncology medicines by applying Foghorn’s proprietary Gene Traffic Control platform, a tool for understanding and modulating the chromatin regulatory system which regulates gene expression by directing the movement of molecules that […]

Page 38 of 117«‹36 373839 40 ›»